For research use only
| Cat No. | ABC-TC3868 |
| Product Type | Vascular Cells |
| Cell Type | Endothelial |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Storage | Liquid Nitrogen |
Primary Human Venous Endothelial Cells are pooled primary isolates from 250 individual human donor umbilical veins.
Human Venous Endothelial Cells (HVECs) are primary cells derived from the venous endothelium, the innermost lining of veins. HVECs exhibit a typical cobblestone-like appearance when cultured in vitro, forming a confluent monolayer with polygonal shapes and tight cell-cell junctions. They regulate vascular tone, blood coagulation, immune responses, and barrier integrity. They produce vasoactive molecules such as nitric oxide (NO) and prostacyclin, which modulate vasodilation and inhibit platelet aggregation. HVECs express the endothelial marker CD31, which is commonly used for endothelial cell identification and reflects their role in vascular adhesion and endothelial function. The cells are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.
| Product Code | Human Venous Endothelial Cells, HVECs, Vein Endothelial Cells, Venous ECs |
| Species | Human |
| Cat.No | ABC-TC3868 |
| Product Category | Primary Cells |
| Size/Quantity | 1 vial |
| Cell Type | Endothelial |
| Growth Mode | Adherent |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Disease | Normal |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Vascular Cells |
| Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Human Venous Endothelial Cells are widely used in biomedical research due to their critical role in vascular physiology and pathology. As primary human systemic vein endothelium representing human primary venous cells, they serve as essential models for studying endothelial barrier function, leukocyte transmigration, and thrombosis mechanisms, providing insights into vascular inflammatory diseases such as atherosclerosis and deep vein thrombosis (DVT).
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).